Medical Condition News

RSS

Anti-obesity medication may help to prevent heart attacks and other major cardiac events

The anti-obesity medication semaglutide may help to prevent heart attacks and other major adverse cardiac events among overweight people who have cardiovascular disease, whether or not they also have heart failure, according to a new study led by UCL's Professor John Deanfield.

22 Aug 2024

New insights into macrophages' role in MASH and liver fibrosis

Formerly known as nonalcoholic steatohepatitis, metabolic dysfunction-associated steatohepatitis (MASH) is an inflammatory disease characterized by liver scarring or fibrosis that progressively impairs liver function.

22 Aug 2024

New 3D imaging tool offers accurate assessment of metabolic health

Mayo Clinic researchers are using artificial intelligence (AI) with an advanced 3D body-volume scanner – originally developed for the clothing industry – to help doctors predict metabolic syndrome risk and severity.

22 Aug 2024

Cancer drug holds promise as a new treatment for neurodegenerative diseases

A type of drug developed for treating cancer holds promise as a new treatment for neurodegenerative diseases such as Alzheimer's, according to a recent study by researchers at Penn State, Stanford University and an international team of collaborators.

22 Aug 2024

Robotic gait training improves mobility in patients with spinal and bulbar muscular atrophy

Spinal and bulbar muscular atrophy (SBMA) is a rare X-linked neuromuscular disorder that results from an abnormal expansion of gene sequences in the androgen receptor gene.

22 Aug 2024

Study reveals how macrophages affect cardiac fibroblast fate post-myocardial infarction

The research uncovers a previously unappreciated mechanism by which macrophages influence the fate of CFs post-MI.

22 Aug 2024

New research challenges belief that weight loss drugs only reduce appetite

A study carried out in St Vincent's University Hospital (SVUH) Dublin challenges the belief that weight loss medications such as Ozempic, Wegovy or Monjaro work just by promoting satiety and making you eat less.

22 Aug 2024

Can a machine learning model accurately predict autism spectrum disorder?

A novel ML algorithm (named ‘AutMedAI’) capable of early autism spectrum disorder (ASD) detection with minimal background and medical information.

22 Aug 2024

AI-driven adaptive deep brain stimulation improves Parkinson’s symptoms

Researchers compare the safety and feasibility of an adaptive deep brain stimulation (aDBS) system to a conventional DBS system for Parkinson's disease.

22 Aug 2024

Creative arts and crafts boost wellbeing in UK adults

Researchers highlight the positive impact of creative arts and crafting on various aspects of wellbeing and loneliness.

22 Aug 2024

New tool could revolutionize cardiovascular risk management: PRESS score validated

The association between platelet hyperreactivity and the risk of cardiovascular events.

22 Aug 2024

Egg consumption linked to slower cognitive decline in women

The effects of egg consumption on cognitive function in older adults.

22 Aug 2024

Research identifies 31 additional cancers potentially linked to obesity

This research identifies 18 potential obesity-related cancers, revealing significant associations with BMI and underscoring obesity's impact on cancer risk.

22 Aug 2024

Study links fine particulate matter exposure to increased risk of gestational diabetes

Researchers assesses the relationship between exposure to fine particulate matter and the risk of gestational diabetes mellitus.

22 Aug 2024

The lingering mental health effects of severe COVID-19

A new study that examined health data on 18 million people reveals a higher incidence of mental illnesses for up to a year following severe COVID-19 in unvaccinated people. Vaccination appeared to mitigate the adverse effects of COVID-19 on mental illnesses. The University of Bristol-led study, published in JAMA Psychiatry on August 21st, 2024, investigated associations of COVID-19 with mental illnesses according to time since diagnosis and vaccination status.

22 Aug 2024

Study challenges migraine-Parkinson's connection

Contrary to previous research, a new study of female participants finds no link between migraine and the risk of developing Parkinson's disease. The study was published on August 21st, 2024, in the online issue of Neurology®, the medical journal of the American Academy of Neurology.

22 Aug 2024

The critical role of PGK1 in Parkinson's disease

An enzyme called PGK1 has an unexpectedly critical role in the production of chemical energy in brain cells, according to a preclinical study led by researchers at Weill Cornell Medicine. The investigators found that boosting its activity may help the brain resist the energy deficits that can lead to Parkinson's disease.

21 Aug 2024

High dose psilocybin shows similar antidepressant effects to escitalopram

High doses of psilocybin - the active ingredient in magic mushrooms - appears to have a similar effect on depressive symptoms as the selective serotonin reuptake inhibitor (SSRI) drug escitalopram, suggests a systematic review and meta-analysis published in The BMJ today.

21 Aug 2024

Belzutifan shows promise in treating advanced renal cell carcinoma

The LITESPARK-005 phase 3 clinical enrolled 746 patients with metastatic clear cell renal cell carcinoma (ccRCC) who had progressed after treatment with both an immune checkpoint inhibitor (ICI) and an anti-angiogenic therapy.

21 Aug 2024

Camu-camu extract reduces liver fat in non-alcoholic fatty liver disease

A research team from Université Laval has shown the benefits of camu-camu on non-alcoholic fatty liver disease, which affects over seven million people in Canada.

21 Aug 2024